Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Indigofera tinctoria leaf extract has many compounds that support its traditional medicinal uses.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The article explains how to rebuild parts of the head and face and how to transplant hair to cover scars, highlighting the need for careful planning and choosing the right method for each patient.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Post-finasteride syndrome's existence is uncertain; more research needed.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

Guasha changed rat skin appearance and blood vessels temporarily without affecting certain nerve proteins or fiber structure.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

Wet cupping blood has different components than regular venous blood, which might affect skin disorder treatments.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.